Neurobiological correlates of cue-reactivity in alcohol-use disorders: a voxel-wise meta-analysis of fMRI studies

J Zeng, S Yu, H Cao, Y Su, Z Dong, X Yang - … & Biobehavioral Reviews, 2021 - Elsevier
Altered brain responses to alcohol-associated stimuli are a neural hallmark of alcohol-use
disorder (AUD) and a promising target for pharmacotherapy. However, findings in cue …

Neural substrates of cue reactivity: association with treatment outcomes and relapse

KE Courtney, JP Schacht, K Hutchison… - Addiction …, 2016 - Wiley Online Library
Given the strong evidence for neurological alterations at the basis of drug dependence,
functional magnetic resonance imaging (fMRI) represents an important tool in the clinical …

The role of the orbitofrontal cortex in alcohol use, abuse, and dependence

DE Moorman - Progress in Neuro-Psychopharmacology and …, 2018 - Elsevier
One of the major functions of the orbitofrontal cortex (OFC) is to promote flexible motivated
behavior. It is no surprise, therefore, that recent work has demonstrated a prominent impact …

[HTML][HTML] Alcohol use disorder in community management of chronic liver diseases

L Leggio, JL Mellinger - Hepatology, 2023 - journals.lww.com
Rising rates of alcohol use disorder (AUD) combined with increases in alcohol‐related liver
disease (ALD) and other liver disease have resulted in the need to develop alcohol …

Varenicline for treatment of alcohol dependence: a randomized, placebo‐controlled trial

A de Bejczy, E Löf, L Walther… - Alcoholism: Clinical …, 2015 - Wiley Online Library
Background Alcohol dependence is a devastating illness affecting a large population, and
new pharmacological treatments with good efficacy are greatly needed. One potential …

Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis

KH Thomas, MN Dalili… - Health …, 2021 - research-information.bris.ac.uk
Background Cigarette smoking is one of the leading causes of early death. Varenicline
[Champix (UK), Pfizer Europe MA EEIG, Brussels, Belgium; or Chantix (USA), Pfizer Inc …

Pharmacotherapy of alcoholism–an update on approved and off-label medications

M Soyka, CA Müller - Expert opinion on pharmacotherapy, 2017 - Taylor & Francis
Introduction: Only a few medications are available for the treatment of alcohol use disorders
(AUDs). Areas covered: This paper discusses approved AUD medications, including the …

Potential medications for the treatment of alcohol use disorder: an evaluation of clinical efficacy and safety

RZ Litten, BB Wilford, DE Falk, ML Ryan… - Substance …, 2016 - journals.sagepub.com
Alcohol use disorder (AUD), as currently defined in the Diagnostic and Statistical Manual,
5th Edition (DSM–5), is a heterogeneous disorder stemming from a complex interaction of …

Neural mechanisms linked to treatment outcomes and recovery in substance-related and addictive disorders

G Mestre-Bach, MN Potenza - Dialogues in Clinical Neuroscience, 2023 - Taylor & Francis
The present review focuses on potential neural mechanisms underlying recovery from
psychiatric conditions characterised by impaired impulse control, specifically substance use …

Effects of alcohol cue reactivity on subsequent treatment outcomes among treatment‐seeking individuals with alcohol use disorder: a multisite randomized, double …

R Miranda Jr, SS O'Malley… - Alcoholism: Clinical …, 2020 - Wiley Online Library
Background The alcohol cue reactivity paradigm is increasingly used to screen medications
for the treatment of alcohol use disorder (AUD) and other substance use disorders. Yet, its …